SpringWorks Therapeutics | 4:持股变动声明-高管 Weinstein Herschel S
SpringWorks Therapeutics | 4:持股变动声明-高管 Pichl Daniel
SpringWorks Therapeutics | 4:持股变动声明-高管 Nofi Michael
SpringWorks Therapeutics | 4:持股变动声明-高管 Perier Francis I Jr
SpringWorks Therapeutics | 4:持股变动声明-高管 Lin Tai-An
SpringWorks Therapeutics | 4:持股变动声明-高管 Islam Saqib
SpringWorks Therapeutics | 4:持股变动声明-高管 Edris Badreddin
SpringWorks Therapeutics | 4:持股变动声明-高管 Ashar Bhavesh
SpringWorks Therapeutics | 4:持股变动声明-高管 Cassidy James
SpringWorks Therapeutics | 8-K:SpringWorks Therapeutics在第43届摩根大通医疗保健年度会议上公布了初步的第四季度和2024年全年财务业绩,并提供了业务最新情况
SpringWorks Therapeutics | 4:持股变动声明-高管 Ashar Bhavesh
SpringWorks Therapeutics | 4:持股变动声明-高管 Weinstein Herschel S
SpringWorks Therapeutics | 4:持股变动声明-高管 Pichl Daniel
SpringWorks Therapeutics | 4:持股变动声明-高管 Perier Francis I Jr
SpringWorks Therapeutics | 4:持股变动声明-高管 Nofi Michael
SpringWorks Therapeutics | 4:持股变动声明-高管 Lin Tai-An
SpringWorks Therapeutics | 4:持股变动声明-高管 Islam Saqib
SpringWorks Therapeutics | 4:持股变动声明-高管 Edris Badreddin
SpringWorks Therapeutics | 4:持股变动声明-高管 Cassidy James
SpringWorks Therapeutics | 4:持股变动声明-高管 Edris Badreddin